Gsk (GSK) EBIT Margin (2009 - 2026)
Gsk (GSK) recorded EBIT Margin of 23.93% in the quarter ended Sep 30, 2026, down 6.40 percentage points from 30.34% a year earlier but up 18.21 percentage points from the prior quarter.
Powered by 
Analysis
Gsk (GSK) EBIT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Gsk's EBIT Margin came in at 22.28% as of Sep 30, 2026, down 1.21 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 24.28%, up 11.47 percentage points from the prior year.
- Annual EBIT Margin has a five-year change of -0.27 percentage points (years ended Dec 2020 to Dec 2025).
- Across earlier years, EBIT Margin came in at 12.82% in the year ended Dec 31, 2024 (-9.42 pp), 22.24% in the year ended Dec 31, 2023 (+0.30 pp), 21.94% in the year ended Dec 31, 2022 (+4.30 pp) and 17.64% in the year ended Dec 31, 2021 (-6.91 pp).
- Quarterly EBIT Margin has ranged from 2.36% in the quarter ended Sep 30, 2024 to 31.89% in the quarter ended Mar 31, 2022 over the past five years.
- On a year-over-year basis, EBIT Margin rose in six of the last eight quarters, with an average year-over-year change of +4.18 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 27.98 percentage points in the quarter ended Sep 30, 2025, against a drop of 21.56 percentage points in the quarter ended Sep 30, 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 5.72% (quarter ended Jun 30, 2026), 30.06% (quarter ended Mar 31, 2026) and 24.28% (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | - |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 28.37% |
| 10 | Gsk | 100.27 Bn | 83.11 Bn | 8.73 Bn | 23.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 23.93% |
| Jun 30, 2026 | 5.72% |
| Mar 31, 2026 | 30.06% |
| Dec 31, 2025 | 24.28% |
| Sep 30, 2025 | 30.34% |
| Jun 30, 2025 | 25.33% |
| Mar 31, 2025 | 29.48% |
| Dec 31, 2024 | 8.57% |
| Sep 30, 2024 | 2.36% |
| Jun 30, 2024 | 20.88% |
| Mar 31, 2024 | 20.24% |
| Dec 31, 2023 | 7.12% |
| Sep 30, 2023 | 23.92% |
| Jun 30, 2023 | 29.83% |
| Mar 31, 2023 | 29.95% |
| Dec 31, 2022 | 25.33% |
| Sep 30, 2022 | 15.21% |
| Jun 30, 2022 | 15.60% |
| Mar 31, 2022 | 31.89% |
| Dec 31, 2021 | 6.95% |
API Access
Gsk EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();